Alpha DNA Investment Management’s Visa V Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,736
Closed -$1.18M 178
2024
Q4
$1.18M Sell
3,736
-134
-3% -$40.3K 0.45% 41
2024
Q3
$1.06M Sell
3,870
-90
-2% -$24.3K 0.4% 51
2024
Q2
$1.04M Sell
3,960
-3,285
-45% -$900K 0.4% 44
2024
Q1
$2.02M Buy
7,245
+3,469
+92% +$958K 0.75% 24
2023
Q4
$983K Sell
3,776
-4,567
-55% -$1.13M 0.38% 46
2023
Q3
$1.92M Sell
8,343
-10,401
-55% -$2.5M 0.79% 22
2023
Q2
$4.45M Buy
18,744
+1,590
+9% +$364K 1.49% 5
2023
Q1
$3.87M Buy
17,154
+7,818
+84% +$1.74M 1.14% 9
2022
Q4
$1.94M Sell
9,336
-2,769
-23% -$558K 0.69% 14
2022
Q3
$2.15M Buy
+12,105
New +$2.46M 1.79% 7

Other funds holding V

Alpha DNA Investment Management's V Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Visa (V) in Q1 2025, closing a stake of 3,736 shares — an estimated $1.18M sold.

Alpha DNA Investment Management first reported a position in V in Q3 2022 and held it in 10 quarters. The position peaked at $4.45M in Q2 2023. 4,279 funds tracked by Wall St. Rank hold V as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Visa position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 3,736 Visa shares in Q1 2025, an estimated $1.18M.
  • Alpha DNA Investment Management first reported a position in Visa in Q3 2022 and held it in 10 quarters.
  • Alpha DNA Investment Management's Visa position peaked at $4.45M in Q2 2023.
  • 4,279 funds tracked by Wall St. Rank held Visa as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.